SE7306960L - - Google Patents
Info
- Publication number
- SE7306960L SE7306960L SE7306960A SE7306960A SE7306960L SE 7306960 L SE7306960 L SE 7306960L SE 7306960 A SE7306960 A SE 7306960A SE 7306960 A SE7306960 A SE 7306960A SE 7306960 L SE7306960 L SE 7306960L
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU68892/74A AU6889274A (en) | 1973-05-17 | 1974-05-14 | Treatment of neurological disorders |
DE2423529A DE2423529A1 (en) | 1973-05-17 | 1974-05-15 | AGENTS FOR TREATMENT OF NEUROLOGICAL DISORDERS |
US05/469,954 US3961060A (en) | 1973-05-17 | 1974-05-15 | Method and compositions for the treatment of neurological disorders |
JP49053962A JPS5029716A (en) | 1973-05-17 | 1974-05-16 | |
FR7417124A FR2229412A1 (en) | 1973-05-17 | 1974-05-16 | |
FI1520/74A FI152074A (en) | 1973-05-17 | 1974-05-16 | |
NL7406689A NL7406689A (en) | 1973-05-17 | 1974-05-17 | |
NO750437A NO750437L (en) | 1973-05-17 | 1975-02-11 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7306960T |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7306960L true SE7306960L (en) | 1974-11-18 |
Family
ID=44715618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7306960A SE7306960L (en) | 1973-05-17 | 1973-05-17 |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE7306960L (en) |
-
1973
- 1973-05-17 SE SE7306960A patent/SE7306960L/xx unknown